CAR T-cell therapy to be funded for three lymphomas

Australia to be one of the few countries to manufacture the treatment

Chimeric antigen receptor (CAR) T-cell therapy for certain relapsed and refractory patients with three types of lymphoma will be publicly funded, Minister for Health Greg Hunt has announced.

# Tags